Clinical trial Recruiting at 1 site Observational Ages 18 and up

Oxygen use and carbon dioxide production after stabilizing blood flow in shock

Official title: Oxygen Consumption And Carbon Dioxide Production Following Hemodynamic Optimization In Shock: The OxyCarDio Study

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07107724 · Data updated 2026-11-12

This project will see if giving fluids or norepinephrine to adults in the ICU with shock changes how much oxygen their bodies use and how much carbon dioxide they make, measured from the ventilator and compared with blood gas calculations.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment36 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Roma)
StatusRecruiting
StartedJuly 29, 2025
Main results expectedJuly 2027
Study endsDecember 2027
Registry record updatedAugust 6, 2025
Trial IDNCT07107724 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Mechanically ventilated adults in the ICU with hypotension and signs of hypoperfusion (for example low urine output, high lactate, or tachycardia) who are candidates for fluid bolus or vasopressor adjustment are ideal candidates.

Probably not a fit

Patients with severe respiratory failure or ARDS, those on or needing veno-arterial ECMO or continuous renal replacement therapy, imminently dying patients, pregnant patients, or those with do-not-resuscitate orders are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study in adult ICU patients with signs of shock who receive standard hemodynamic optimization such as fluid boluses or vasopressors. VO2 and VCO2 will be measured continuously using a dedicated ventilator-based gas monitor and compared with values calculated from veno-arterial dissolved gas measurements. Patients will also receive advanced hemodynamic monitoring with the MostCare Up device and clinical management will follow current guidelines and treating physicians' decisions. The study aims to describe immediate changes in exhaled gas metrics after common resuscitation maneuvers and to test agreement between exhaled and blood-based measurements.

Why it matters

Potential benefit: If successful, this approach could provide a noninvasive, bedside way to track tissue oxygen use and guide resuscitation in ventilated patients with shock.

How similar studies have gone: Some prior studies have shown feasibility of measuring VO2 and VCO2 from exhaled gas in ventilated patients, but direct comparison with veno-arterial dissolved gas and response to hemodynamic maneuvers remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Hypotension (MAP\< 65mmHg or sudden drop in MAP \> 15 mmHg) and one of the following conditions:

* Heart rate \> 120 bpm
* Urinary output \< 0.5 ml/kg/h for at least two hours
* Lactate \> 2 mmol/L

Exclusion Criteria:

* Urgent need for surgery
* Urgent need for veno-arterial ECMO or severe hemodynamic instability
* Consistent risk of imminent death
* Severe ARDS or severe respiratory failure (p/F \< 100 mmHg) and/or FiO2\>0.8
* Severe heart failure (NYHA 4 and/or EF\<25%)
* Need for intermittent or continuous renal replacement therapy (IRRT or CRRT)
* Anemia defined as Hb\<8 g/dL
* VO2 variability \< 5% throughout ten minutes of stabilization before procedure start
* Intraabdominal hypertension, defined as intraabdominal pressure \> 18 mmHg
* Pregnancy
* Withdrawal or refuse of informed consent
* Terminal disease
* Do-not-resuscitate order.

Where it's running

  • Policlinico Universitario Fondazione Agostino Gemelli IRCCS
    Roma, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.